Page History

...

The FDA has established a list of harmful and potentially harmful constituents ( HPHCs ) in tobacco products and tobacco smoke (see https://www.fda.gov/tobacco-products/). Additionally, There there is a  list of 20 HPHCs, selected from the full list of HPHCs, for which testing methods are well established and widely available. The HPHC list focuses on chemicals that are linked to the five 5 most serious health effects of tobacco use (i.e., cancer, cardiovascular disease, respiratory effects, reproductive problems, and addiction.) 

The use of tobacco products result in the uptake of nicotine and a wide range of other chemicals. Biomarkers of exposure to tobacco and nicotine delivery products are limited to the chemicals taken up during product use or during exposure to product emissions. Total nicotine equivalents (TNE) is a biomarker of nicotine consumption, defined as the molar sum of the urinary concentrations of nicotine and all of its known metabolites (e.g. Typically, this includes total nicotine, total cotinine, total 3-hydroxycotinine, and nicotine N-oxide (NNO)), is a biomarker of nicotine consumption. Cotinine is a metabolite of nicotine and is a widely used biomarker of nicotine exposure. Nicotine replacement therapy and tobacco use can be distinguished by the detection of a tobacco-specific alkaloid , such as anabasine. Cotinine has 6 notable metabolites including: (i.e., 3-hydroxycotinine, cotinine glucuronide, 5-hydroxycotinine, cotinine N-oxide, cotinine methonium ion, and norcotinine).

Biomarkers of exposure may be used to evaluated the pharmacokinetics of tobacco products. After the specific tobacco product is used, these biomarkers are measured serially to determine well-defined pharmacokinetic parameters ( e.g., AUC, TMX, T 1/2 ), ; the concentration level at the pre-specified levels at prespecified timepoints would be represented in the PC/PK SDTM domains (Section 3.3.3.2, Pharmacokinetics Concentration and Parameters (PC, PP)). Otherwise, these biomarkers would be represented in the Laboratory Testing Results (LB) domain. 

...